[go: up one dir, main page]

AU2003211993A1 - (1,2,4)TRIAZOLO(1,5-c)PYRIMIDINE DERIVATIVES - Google Patents

(1,2,4)TRIAZOLO(1,5-c)PYRIMIDINE DERIVATIVES

Info

Publication number
AU2003211993A1
AU2003211993A1 AU2003211993A AU2003211993A AU2003211993A1 AU 2003211993 A1 AU2003211993 A1 AU 2003211993A1 AU 2003211993 A AU2003211993 A AU 2003211993A AU 2003211993 A AU2003211993 A AU 2003211993A AU 2003211993 A1 AU2003211993 A1 AU 2003211993A1
Authority
AU
Australia
Prior art keywords
triazolo
pyrimidine derivatives
pyrimidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003211993A
Inventor
Hironori Imma
Tomoyuki Kanda
Yoshihisa Kuwana
Junichi Shimada
Shizuo Shiozaki
Tomokazu Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of AU2003211993A1 publication Critical patent/AU2003211993A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003211993A 2002-02-15 2003-02-14 (1,2,4)TRIAZOLO(1,5-c)PYRIMIDINE DERIVATIVES Abandoned AU2003211993A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-37819 2002-02-15
JP2002037819 2002-02-15
PCT/JP2003/001565 WO2003068776A1 (en) 2002-02-15 2003-02-14 [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES

Publications (1)

Publication Number Publication Date
AU2003211993A1 true AU2003211993A1 (en) 2003-09-04

Family

ID=27678133

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003211993A Abandoned AU2003211993A1 (en) 2002-02-15 2003-02-14 (1,2,4)TRIAZOLO(1,5-c)PYRIMIDINE DERIVATIVES

Country Status (3)

Country Link
JP (1) JPWO2003068776A1 (en)
AU (1) AU2003211993A1 (en)
WO (1) WO2003068776A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004029056A1 (en) * 2002-09-24 2004-04-08 Kyowa Hakko Kogyo Co., Ltd. [1,2,4]-TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVE
ATE418555T1 (en) * 2003-04-09 2009-01-15 Biogen Idec Inc A2A ADENOSIN RECEPTOR ANTAGONISTS
WO2004092177A1 (en) 2003-04-09 2004-10-28 Biogen Idec Ma Inc. Triazolopyrazines and methods of making and using the same
WO2004092170A2 (en) 2003-04-09 2004-10-28 Biogen Idec Ma Inc. Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagon ists
US8859538B2 (en) 2007-06-21 2014-10-14 Cara Therapeutics, Inc. Uses of substituted imidazoheterocycles
US7517874B2 (en) 2007-06-21 2009-04-14 Cara Therapeutics, Inc. Substituted imidazo[1,5-a][1,4]diazepines and imidazo[1,5-a]pyrazines as cannabinoid receptor agonists for the treatment of pain
AU2009208947B2 (en) 2008-02-01 2014-02-06 Takeda Pharmaceutical Company Limited Oxim derivatives as HSP90 inhibitors
EP3347363B1 (en) * 2015-09-09 2020-01-01 H. Hoffnabb-La Roche Ag N-(3-azabicyclo[3.2.1]octan-8-yl)-8-(4-phenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[l,5-a]pyridin-2-amine derivatives as gamma-secretase modulators for treating alzheimer's disease
CA3005353A1 (en) 2015-11-20 2017-05-26 Forma Therapeutics, Inc. Purinones as ubiquitin-specific protease 1 inhibitors
JP7111733B2 (en) 2017-03-16 2022-08-02 江蘇恒瑞医薬股▲ふん▼有限公司 Heteroaryl[4,3-c]pyrimidin-5-amine derivatives, methods for their preparation, and pharmaceutical uses thereof
CR20200441A (en) 2018-02-27 2021-03-15 Incyte Corp Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors
MX2020012376A (en) 2018-05-18 2021-03-09 Incyte Corp Fused pyrimidine derivatives as a2a / a2b inhibitors.
IL279829B2 (en) 2018-07-05 2025-05-01 Incyte Holdings Corp Fused pyrazine derivatives as a2a / a2b inhibitors
EP3883575B1 (en) * 2018-11-20 2025-10-08 Merck Sharp & Dohme LLC Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
TWI829857B (en) 2019-01-29 2024-01-21 美商英塞特公司 Pyrazolopyridines and triazolopyridines as a2a / a2b inhibitors
MX2023012338A (en) * 2021-04-23 2023-10-30 Chong Kun Dang Pharmaceutical Corp Compound as adenosine a2a receptor antagonist and pharmaceutical composition comprising same.
CN115626922A (en) * 2021-04-29 2023-01-20 苏州恩华生物医药科技有限公司 5,6,7,8-tetrahydropyrido [4,3-d ] pyrimidin-4-ol derivatives and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0976753B1 (en) * 1997-03-24 2004-01-02 Kyowa Hakko Kogyo Co., Ltd. [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES
HUP0103921A3 (en) * 1998-09-22 2002-12-28 Kyowa Hakko Kogyo Kk [1,2,4]triazolo[1,5-c]pyrimidine derivatives and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
WO2003068776A1 (en) 2003-08-21
JPWO2003068776A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
AU2003242252A1 (en) Bicyclic pyrimidine derivatives
AU2003233519A1 (en) Process for imidazo(4,5-c)pyridin-4-amines
EP1599482A4 (en) Pyrazolo 1,5-a pyrimidine derivatives
AU2003292007A1 (en) 4-AMINO-5-PHENYL-7-CYCLOHEXYL-PYRROLO(2,3-d)PYRIMIDINE DERIVATIVES
AU2003248588A1 (en) Substituted pyrrolopyridines
EP1416935B8 (en) 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
AU2003245700A1 (en) Pyrazolopyridine derivatives
AU2003280680A1 (en) Xanthine compound
AU2003209077A1 (en) Pyrimidine compounds
PL1608654T3 (en) 8-SUBSTITUTED-6, 7, 8,9-TETRAHY9DROPYRIMIDO (1,2- a) PYRIMIDIN-4-ONE DERIVATIVES
AU2003281477A1 (en) 4-amino-substituted pyrimidine derivatives
PT1608653E (en) Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido (1,2- a) pyrimidin-4-one derivatives
AU2003300522A1 (en) 4-phenyl-pyrimido (4,5-b) indole derivatives
AU2003211993A1 (en) (1,2,4)TRIAZOLO(1,5-c)PYRIMIDINE DERIVATIVES
AU2003272886A1 (en) (1,2,4)-TRIAZOLO(1,5-c)PYRIMIDINE DERIVATIVE
AU2002362806A1 (en) Pyrimidine derivatives
AU2003287992A1 (en) Cyclohexylurea derivatives
AU2003208467A1 (en) Pyrimidine compounds
AU2003229657A1 (en) Triazolopyrimidines
AU2003215676A1 (en) Pyrazolopyrimidines derivatives
AU2003296564A1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives
AU2003226725A1 (en) Pyrazolopyrimidine derivatives
AU2003223475A1 (en) Substituted pyrazine derivatives
AU2003205130A1 (en) Oxothieno (3, 2-b) pyridinecarboxamides as antiviral agents
AU2003231459A1 (en) Pyrimidine derivative

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase